Overview

Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
0
Participant gender:
All
Summary
This study is conducted in Europe. The aim of this observational study is to observe the efficacy of Levemir® treatment in patients with type 2 diabetes in everyday clinical practice in Switzerland. Furthermore the time period between diagnosis of type 2 diabetes and insulin initiation is evaluated.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- Patients with type 2 diabetes mellitus

- Insulin-naive or currently treated with another basal insulin

- Inclusion of patients at the discretion of the treating physician after the decision
to prescribe Levemir®

Exclusion Criteria:

- Type 1 diabetes mellitus

- Patients treated with short acting or with premix insulin

- Women who are pregnant, breast feeding or have the intention to become pregnant

- Known or suspected allergy to the study product or related product

- Any exclusion criteria according to the Swiss Levemir® SPC (Summary of Product
Characteristics)